ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000

DCT Board Ok’s PA, BRM Contract Concepts

October 30, 1992

Phase II Study Tests Chemo Plus Mylotarg For AML

December 27, 2002

Judge Rules Privacy Act Not Applicable In Bernard Fisher’s Suit Against HHA

July 5, 1996

In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos

May 9, 1997

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000